Principle and Co-Investigators
Dr. Janine Hutson
Dr. Janine Hutson received her PhD from the Department of Clinical Pharmacology and Toxicology at the University of Toronto, where she focused on drug safety and addiction during pregnancy. She then pursued the MD/PhD program at the same institution, obtaining her MD. Subsequently, Dr. Hutson completed her Obstetrics and Gynecology residency and research fellowship at the University of Western Ontario/London Health Sciences Center. Presently, she works as a High-Risk Obstetrician and Clinician Scientist, leading an innovative maternal health research program at London Health Sciences Center in London, Ontario. Additionally, she is an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Western.
Dr. Facundo Garcia-Bournissen
Dr. Facundo Garcia-Bournissen is a pediatrician, clinical pharmacologist, and clinician scientist who currently serves as the Head of the Division of Pediatric Clinical Pharmacology at the Department of Pediatrics, London Health Sciences Centre in London, Ontario, Canada. He earned his MD and completed his pediatric specialty training at the University of Buenos Aires, followed by post-graduate training at Hôpital Ste. Justine in Canada. Dr. Garcia-Bournissen also obtained his PhD, clinical pharmacology fellowship, and clinician scientist training at the University of Toronto in Canada. His current research primarily focuses on the clinical and basic pharmacology of medications for neglected diseases in children and vulnerable populations. He is actively involved in the design and implementation of clinical trials and basic research in these conditions.
Dr. Garcia-Bournissen holds the position of Associate Professor in the Departments of Pediatrics, Medicine, Epidemiology & Biostatistics, and Pharmacology & Physiology at Schulich School of Medicine & Dentistry, University of Western Ontario.
Dr. Hutson and Dr. Garcia-Bournissen have previously collaborated as a team while pursuing their training at the University of Toronto. Together, they have contributed to several peer-reviewed publications, including the validation of the placental perfusion model to predict in vivo placental transfer in humans (Hutson et al., 2011).
Their expertise in drug safety during pregnancy has been recognized by the Society of Obstetricians and Gynecologists of Canada (SOGC), and they were recently involved in the development of a Society Statement on the safety of acetaminophen in pregnancy.
